Atherosclerotic Cardiovascular DiseasePhase 3MARITIME-CVNCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Phase 3 study testing Maridebart Cafraglutide in people with Atherosclerotic Cardiovascular Disease and Overweight, run by Amgen at 783 sites in 36 countries.
Trial summary
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality. Read more about this study
- Who is it for?
- Ages 45 to 99 years
- Conditions the study is for
- Atherosclerotic Cardiovascular Disease, Overweight, Obesity
- What is being tested?
- Maridebart Cafraglutide
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 12,800 participants
- Where
- 783 sitesin 36 countries
- Study dates
- 25 Jul 2025to 29 Sep 2030
- Phase
- Phase 3
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥ 45 years at screening.
- BMI of ≥ 27.0 kg/m^2 at screening.
- History of Atherosclerotic Cardiovascular Disease (ASCVD) with a documented history of at least one of the following:
- Prior MI (presumed atherothrombotic event due to plaque rupture/erosion).
- Prior ischemic stroke (presumed due to atherosclerosis; may include ischemic stroke with hemorrhagic transformation).
- Symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) < 0.9 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease.
Who cannot join
- History of any of the following within 60 days before screening or between screening and randomization: MI, hospitalization for unstable angina, arterial revascularization (eg, coronary, cerebrovascular or peripheral) major cardiovascular surgery, stroke, or transient ischemic attack (TIA).
- New York Heart Association (NYHA) class IV HF during screening or hospitalization for HF within 60 days before screening or between screening and randomization.
- Type 1 DM, or any other type of diabetes with the exception of T2DM or prior gestational diabetes. Participants with a history of gestational diabetes should be stratified according to their current diabetes classification.
- For participants with T2DM (including those without a prior history of T2DM but with a HbA1c ≥ 6.5% during screening):
- HbA1c > 10.0% (86 mmol/mol) at screening.
- History of diabetic ketoacidosis or hyperosmolar state/coma within 12 months before randomization.
Show all 15Show fewer
- One or more episodes of severe hypoglycemia within 6 months before randomization and/or history of hypoglycemia unawareness.
- History of proliferative diabetic retinopathy, diabetic maculopathy, severe non-proliferative diabetic retinopathy, or currently receiving or planning to receive treatment for diabetic retinopathy and/or diabetic macular edema.
- Use of any glucagon-like peptide-1 receptor agonist (GLP-1 RA), glucose-dependent insulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within 90 days before randomization or planned use during the conduct of the trial.
- History of chronic pancreatitis or history of acute pancreatitis in the 180 days before screening or between screening and randomization.
- Family (first-degree relative[s]), or personal history of medullary thyroid carcinoma (MTC), or multiple endocrine neoplasia syndrome type 2 (MEN-2).
- Calcitonin ≥ 50 ng/L (pg/mL) at screening.
- Acute or chronic hepatitis; signs and symptoms of any liver disease other than metabolic dysfunction-associated steatotic liver disease, or alanine aminotransferase (ALT) > 3.0 x the upper limit of normal (ULN) during screening, or total bilirubin (TBL) > 1.8 x ULN during screening (for participants with a known diagnosis of Gilbert syndrome, direct bilirubin should be used instead of TBL).
- History of malignancy within the last 5 years before screening or between screening and randomization (except for the following treated with curative intent: non-melanoma skin cancer, breast ductal carcinoma in situ, cervical carcinoma in situ, or prostate cancer in situ).
- Participants of childbearing potential planning to become pregnant while on study or unwilling to use protocol-specified methods of contraception during treatment.
Trial locations and contacts
783 sites in 36 countries.
783 sites in 36 countries
United States140 sites
PharmaTex Research, LLC
Amarillo, Texas, 79106
McFarland Clinic PC
Ames, Iowa, 50010
Endeavor Health-Northwest Community Healthcare
Arlington Heights, Illinois, 60005
Austin Heart
Austin, Texas, 78705
Velocity Clinical Research - Austin
Austin, Texas, 78759
Ascension Saint Agnes Heart Care
Baltimore, Maryland, 21229
Velocity Clinical Research - Cleveland
Beachwood, Ohio, 44122
Heritage Valley Multispecialty Group Inc
Beaver, Pennsylvania, 15009
Velocity Clinical Research - Binghamton
Binghamton, New York, 13905
Excel Medical Clinical Trials
Boca Raton, Florida, 33434
Brigham and Womens Hospital
Boston, Massachusetts, 02115
Capital Area Research LLC
Camp Hill, Pennsylvania, 17011
East Coast Institute for Research LLC at Canton Georgia
Canton, Georgia, 30114
Aultman Hospital, Cardiovascular Consultants, Inc
Canton, Ohio, 44710
Novant Health Heart and Vascular Institute
Charlotte, North Carolina, 28204
Eagle Clinical Research
Chicago, Illinois, 60621
University of Chicago
Chicago, Illinois, 60637
Velocity Clinical Research - Auburn
Cincinnati, Ohio, 45219
StudyMetrix Research
City of Saint Peters, Missouri, 63303
Endocrinology Associates Inc
Columbus, Ohio, 43201
Valley Clinical Trials, LLC dba Flourish Research
Covina, California, 91723
Cardiovascular Associates Research, LLC
Covington, Louisiana, 70433
Vaught Neurological Services
Crab Orchard, West Virginia, 25827
Thyroid Endocrinology and Diabetes
Dallas, Texas, 75208
Soltero Cardiovascular Research Center
Dallas, Texas, 75226
Zenos Clinical Research
Dallas, Texas, 75230
Cedar Health Research, LLC
Dallas, Texas, 75251
University of Texas Southwestern Medical Center
Dallas, Texas, 75390
Alliance For Multispecialty Research - Daphne
Daphne, Alabama, 36526
Midwest Cardiovascular Research Foundation
Davenport, Iowa, 52801
Velocity Clinical Research - Durham
Durham, North Carolina, 27701
Velocity Clinical Research - Providence
East Greenwich, Rhode Island, 02818
Velocity Clinical Research - New Smyrna Beach
Edgewater, Florida, 32132
David Turbay, MD
El Paso, Texas, 79905
Academy of Diabetes Thyroid and Endocrine
El Paso, Texas, 79935
Inova Cardiology - Fairfax
Fairfax, Virginia, 22031
Eastern Shore Research Institute
Fairhope, Alabama, 36532
Virginia Heart
Falls Church, Virginia, 22042
Alliance for Multispecialty Research - Fort Myers
Fort Myers, Florida, 33912
Stern Cardiovascular Foundation Inc
Germantown, Tennessee, 38138
Moses H Cone Memorial Hospital
Greensboro, North Carolina, 27401
Elite Cardiac Research Center LLC
Hialeah, Florida, 33013
Elite Clinical Research
Hialeah, Florida, 33018
Zenith Clinical Research
Hollywood, Florida, 33021
Encore Medical Research LLC
Hollywood, Florida, 33024
Abington Medical Specialists
Horsham, Pennsylvania, 19044
Biopharma Informatic, LLC
Houston, Texas, 77043
Cardiovascular Specialists of Willowbrook
Houston, Texas, 77070
PlanIt Research, PLLC
Houston, Texas, 77079
Research Physicians Network, LLC
Houston, Texas, 77089
Vital Heart and Vein
Humble, Texas, 77338
Velocity Clinical Research- Huntington Park
Huntington Park, California, 90255
Huntsville Clinical Research, LLC
Huntsville, Alabama, 35801
Jackson Heart Clinic
Jackson, Mississippi, 39216
East Coast Institute for Research, LLC
Jacksonville, Florida, 32216
Alliance for Multispecialty Research - Kansas City
Kansas City, Missouri, 64114
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, 64128
Tcr Institute Llc
Kingwood, Texas, 77339
Accellacare of Knoxville
Knoxville, Tennessee, 37912
Velocity Clinical Research- Los Angeles
La Mesa, California, 91942
Orange County Research Center
Lake Forest, California, 92630
Helium Research Group
Lake Jackson, Texas, 77566
Clinical Research of Central Florida
Lakeland, Florida, 33805
Excel Clinical Research
Las Vegas, Nevada, 89109
Vector Clinical Trials
Las Vegas, Nevada, 89128
Epic Clinical Research
Lewisville, Texas, 75057
Nexgen Research
Lima, Ohio, 45801
Bryan Heart
Lincoln, Nebraska, 68506
Monroe Biomedical Research
Louisville, Kentucky, 40213
The Jones Center Clinical Research
Macon, Georgia, 31210
Fairview Health Services M Health Fairview St Johns Hospital
Maplewood, Minnesota, 55109
South Florida Clinical Research
Margate, Florida, 33063
Tandem Clinical Research - Marrero
Marrero, Louisiana, 70072
Biopharma Informatic-McAllen
McAllen, Texas, 78503
Velocity Clinical Research - Boise
Meridian, Idaho, 83642
Southern Endocrinology Associates PA
Mesquite, Texas, 75149
Finlay Medical Research
Miami, Florida, 33126
Suncoast Research Group LLC
Miami, Florida, 33135
New Horizon Research Center
Miami, Florida, 33165
Panax Clinical Research
Miami Lakes, Florida, 33014
San Marcus Research Clinic Inc
Miami Lakes, Florida, 33014
Indago Research and Health Center
Miami Lakes, Florida, 33016
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407
Mobile Heart Specialists PC
Mobile, Alabama, 36608
Monroe Biomedical Research
Monroe, North Carolina, 28112
West Clinical Research
Morehead City, North Carolina, 28557
Burke Primary Care Family Practice
Morganton, North Carolina, 28655
Accellacare Charleston
Mt. Pleasant, South Carolina, 29464
Cardiovascular Research of Northwest Indiana LLC
Munster, Indiana, 46321
Btc of New Bedford
New Bedford, Massachusetts, 02740
Alliance for Multispecialty Research - Norman
Norman, Oklahoma, 73069
North Hills Medical Research
North Richland Hills, Texas, 76180
Alliance For Multispecialty Research - Oak Brook
Oak Brook, Illinois, 60523
West Orange Endocrinology
Ocoee, Florida, 34761
University of Nebraska Medical Center
Omaha, Nebraska, 68198
MD Medical Research
Oxon Hill, Maryland, 20745
Cardiology Partners Clinical Research Institute
Palm Beach Gardens, Florida, 33410
Primary Clinical Research
Papillion, Nebraska, 68046
Synexus Clinical Research US, Inc.
Phoenix, Arizona, 85020
Medical Advancement Centers of Arizona
Phoenix, Arizona, 85044
Peace River Cardiovascular Center
Port Charlotte, Florida, 33952
Progressive Medical Research
Port Orange, Florida, 32127
Hudson Valley Cardiovascular Practice PC
Poughkeepsie, New York, 12601
Cardiovascular Research of Knoxville North Knoxville Medical Center
Powell, Tennessee, 37849
Boeson Research
Provo, Utah, 84604
Accellacare of Raleigh
Raleigh, North Carolina, 27609
Monument Health Clinical Research
Rapid City, South Dakota, 57701
Biopharma Informatic - The Cardiovascular Center
Redding, California, 96001
Rochester Clinical Research
Rochester, New York, 14609
Velocity Clinical Research - Rockville
Rockville, Maryland, 20854
Saint Johns Center for Clinical Research
Saint Augustine, Florida, 32086
Bandera Family Health Care
San Antonio, Texas, 78249
Acclaim Clinical Research
San Diego, California, 92120
Intercoastal Medical Group
Sarasota, Florida, 34239
Saratoga Clinical Research, LLC
Saratoga Springs, New York, 12866
Velocity Clinical Research - Savannah
Savannah, Georgia, 31419
VA Puget Sound Healthcare System
Seattle, Washington, 98108
Consano Clinical Research - Shavano Park
Shavano Park, Texas, 78231
Syed Research Consultants LLC
Sheffield, Alabama, 35660
CardioMetabolic Collaborative Clinic
Somerset, New Jersey, 08873
Velocity Clinical Research - Spokane
Spokane, Washington, 99218
Encompass Clinical Research
Spring Valley, California, 91978
Prarie Education and Research
Springfield, Illinois, 62701
Saint Louis Heart and Vascular PC
St Louis, Missouri, 63136
Accellacare of Piedmont Healthcare
Statesville, North Carolina, 28625
Sugar Lakes Family Practice
Sugar Land, Texas, 77479
Cotton-ONeil Diabetes and Endocrinology Center
Topeka, Kansas, 66606
Tennessee Center for Clinical Trials
Tullahoma, Tennessee, 37388
Cardiology Associates of North Mississippi
Tupelo, Mississippi, 38801
Velocity Clinical Research - Valparaiso
Valparaiso, Indiana, 46383
Diablo Clinical Research
Walnut Creek, California, 94598
Aspirus Cardiovascular Associates
Wausau, Wisconsin, 54401
Focus Clinical Research
West Hills, California, 91307
Velocity Clinical Research - Salt Lake City
West Jordan, Utah, 84088
Southgate Medical Group
West Seneca, New York, 14224
Wichita Falls Heart Clinic
Wichita Falls, Texas, 76301
Family Practice Associates
Wilmington, Delaware, 19805
Brookview Hills Research Associates Llc
Winston-Salem, North Carolina, 27103
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
Winter Haven Hospital
Winter Haven, Florida, 33881
Czechia41 sites
Innera sro
Benešov, 256 01
Medicentrum Beroun as
Beroun, 266 01
MUDr Libor Nechvatal sro
Brno, 602 00
Centrum pro zdravi sro
Brno, 603 00
MUDr Karel Kamenik sro
Brno, 603 00
Kardiologicka ambulance Brno sro
Brno, 612 00
Fakultni nemocnice Brno
Brno, 625 00
Vojenska nemocnice Brno
Brno, 636 00
Amkardia sro
Brno, 639 00
CorMedico sro
Bruntál, 792 01
Kardio Chlumec sro
Chlumec nad Cidlinou, 503 51
Ordinace pro choroby srdce sro
Chomutov, 430 02
Dika centrum sro
Havirov - Mesto, 736 01
Edumed sro
Hradec Králové, 500 02
Nemocnice Jihlava po
Jihlava, 586 33
Interna a diabetologie MUDr Vodickova sro
Liberec, 460 01
Kardiologie - Liberec sro
Liberec, 460 01
Edumed sro
Náchod, 547 01
Interni a diabetologicka ordinace sro
Náchod, 547 01
PreventaMed sro
Olomouc, 779 00
Ostin sro
Ostrava, 700 30
CCR Ostrava sro
Ostrava, 702 00
MUDr Miroslav Koliba sro
Ostrava, 702 00
Diahelp sro
Pardubice, 530 02
Pratia Czech sro
Pardubice, 530 02
Kardiologie a Angiologie Praha sro - Komplexni Centrum Vyzkumu, Prevence a Lecby Kardiov Nemoci
Prague, 101 00
Kardiologie a angiologie sro
Prague, 101 00
Avicena - kardiologie, interna sro
Prague, 110 00
Kardiologie Vinohrady sro
Prague, 110 00
Kardiologie Vinohrady sro
Prague, 120 00
Institut klinicke a experimentalni mediciny
Prague, 140 21
Milan Kvapil sro
Prague, 149 00
Restrial sro
Prague, 181 00
Endokrinologie Cerny Most sro
Prague, 198 00
Kardiologie Cor sro
Praha 10 - Zabehlice, 106 00
Kardio Vaclavik sro
Přerov, 750 02
MUDr Jarmila Otrubova
Prostějov, 796 01
Nemocnice Slany
Slaný, 274 01
MUDrych sro
Svitavy, 568 02
Clinical Trials Service sro
Uherské Hradiště, 686 01
Kardiologie - Usti nad Labem sro
Ústí nad Labem, 400 01
China40 sites
Beijing Hospital
Beijing, Beijing Municipality, 100020
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050
Peking University Third Hospital
Beijing, Beijing Municipality, 100191
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, 233300
The First Bethune Hospital of Jilin University
Changchun, Jilin, 130021
China Japan Union Hospital of Jilin University
Changchun, Jilin, 130033
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011
West China Hospital Sichuan University
Chengdu, Sichuan, 610041
Chengdu Fifth Peoples Hospital
Chengdu, Sichuan, 611130
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Sichuan, 400010
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, 510080
Sun Yat-sen Memorial Hospital Sun Yat-sen University
Guangzhou, Guangdong, 510120
The Fourth Hospital of Harbin Medical University
Harbin, Heilongjiang, 150001
Huizhou Central Peoples Hospital
Huizhou, Guangdong, 516001
Jinan Central Hospital
Jinan, Shandong, 250013
The First Affiliated Hospital of Henan University of Science And Technology
Luoyang, Henan, 471000
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011
Nanjing First Hospital
Nanjing, Jiangsu, 210012
Zhongda Hospital Southeast University
Nanjing, Jiangsu, 211000
The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, 315010
First Hospital of Qinhuangdao
Qinhuangdao, Hebei, 066099
Shanghai Ninth Peoples Hospital Affiliated Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, 200011
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, 200032
Shanghai Tenth Peoples Hospital
Shanghai, Shanghai Municipality, 200072
The Fifth Peoples Hospital of Shanghai, Fudan University
Shanghai, Shanghai Municipality, 200240
The Peoples Hospital of Liaoning Province
Shenyang, Liaoning, 110016
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000
Tianjin Peoples Hospital
Tianjin, Tianjin Municipality, 300121
Teda International Cardiovascular Hospital
Tianjin, Tianjin Municipality, 300457
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, 430022
Wuxi Peoples Hospital
Wuxi, Jiangsu, 214023
Shaanxi Provincial Peoples Hospital
Xi'an, Shaanxi, 710068
Xi'an Daxing Hospital
Xi'an, Shaanxi, 710082
The First Affiliated Hospital of Xi An Jiao Tong University
Xi’an, Shanxi, 710061
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, 221006
The First Peoples Hospital of Yulin
Yulin, Guangxi, 537006
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212001
Germany39 sites
Zentrum fuer klinische Studien Bad Homburg
Bad Homburg, 61348
Universitaets-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen, 79189
Universitaetsklinikum der Ruhr-Universitaet Bochum
Bad Oeynhausen, 32545
Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin
Berlin, 12203
Studienzentrum Dr. Braun GmbH
Berlin, 13187
Charite - Universitaetsmedizin Berlin, Campus Virchow
Berlin, 13353
Berufsgenossenschaftliches Universitaetsklinikum Bergmannsheil gGmbH
Bochum, 44789
Universitaetsklinikum Bonn
Bonn, 53127
Klinikum Lippe
Detmold, 32756
Diabeteszentrum Dortmund
Dortmund, 44137
Sankt-Johannes-Hospital
Dortmund, 44137
Cardiologicum Dresden und Pirna Facharztpraxis für Kardiologie und Angiologie
Dresden, 01277
Universitaetsklinikum Dresden
Dresden, 01307
Zentrum fuer Klinische Studien Suedbrandenburg GmbH
Elsterwerda, 04910
Praxis am Markt Dr. Bernd Becker
Essen, 45355
Unterfrintroper Hausarztzentrum
Essen, 45359
Universitaetsklinikum Frankfurt
Frankfurt am Main, 60590
ClinPhenomics CVC GmbH
Frankfurt am Main, 60596
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, 20251
Cardiologicum Hamburg GbR
Hamburg, 22041
Diabeteszentrum Hamburg West
Hamburg, 22607
Diabetologische Schwerpunktpraxis Hohenmoelsen
Hohenmölsen, 06679
Kardiopraxis Schirmer
Kaiserslautern, 67655
Braun Ambulantes Herzzentrum Kassel
Kassel, 34121
Universitaetsklinikum Leipzig
Leipzig, 04103
AmBeNet GmbH
Leipzig, 04107
Universitaetsklinikum Schleswig-Holstein - Luebeck
Lübeck, 23538
Otto von Guericke Universitaet Magdeburg
Magdeburg, 39120
Kardiologische Praxis Doktor Jens Taggeselle
Markkleeberg, 04416
Klinikum rechts der Isar der TUM
München, 80636
Centrum für Diagnostik und Gesundheit
München, 80809
Institut für Diabetesforschung Münster GmbH
Münster, 48145
Universitaetsklinikum Muenster
Münster, 48149
Praxis Segner - Dr. Braun - Kirsch
Oberwürzbach, 66386
Red-Institut GmbH
Oldenburg, 23758
Kardiologische Gemeinschaftspraxis Papenburg
Papenburg, 26871
Praxis Reinfeld Mitte Dr Joachim Weimer und Dr Katharina Pfeiffer
Reinfeld (Holstein), 23858
Zentrum fuer klinische Forschung Allgaeu Oberschwaben
Wangen, 88239
Praxis Dr med Ayham Al-Zoebi Facharzt fuer Innere Medizin und Kardiologie
Wermsdorf, 04779
Poland39 sites
Niepubliczny Zaklad Opieki Zdrowotnej Vita Diabetica Malgorzata Buraczyk
Bialystok, 15-879
American Heart of Poland Spolka Akcyjna Polsko-Amerykanskie Kliniki Serca
Bielsko-Biala, 43-316
Centrum Medyczne Kermed - Renata Bijata-Bronisz i Ewa Kowalinska Spolka Jawna
Bydgoszcz, 85-231
Centrum Medyczne Lukamed Spzoo
Chojnice, 89-600
American Heart of Poland Spolka Akcyjna
Chrzanów, 32-500
Etg Lublin Spzoo
Dębica, 39-200
Futuremeds Spolka z ograniczona odpowiedzialnoscia
Gdynia, 81-384
Emc Silesia Spolka z ograniczona odpowiedzialnoscia
Katowice, 40-353
Salvia-Lekston i Madej Spolka Jawna
Katowice, 40-772
American Heart of Poland Spolka Akcyjna Polsko-Amerykanskie Kliniki Serca
Kędzierzyn-Koźle, 47-200
Medyczne Centrum Diabetologiczno-Endokrynologiczno-Metaboliczne Diab-Endo-Met Sp zoo
Krakow, 31-261
Unicardia And Unimedica And Uniestetica
Krakow, 31-271
Futuremeds spolka z ograniczona odpowiedzialnoscia
Krakow, 31-501
Beata Miklaszewicz i Dariusz Dabrowski Cardiamed Spolka Jawna
Legnica, 59-220
Futuremeds spolka z ograniczona odpowiedzialnoscia
Lodz, 91-363
Clinical Best Solutions Sp zoo Spolka Komandytowa Gabinet Lekarski
Lublin, 20-011
Ekamed Spolka z Ograniczona Odpowiedzialnoscia
Lublin, 20-718
Futuremeds spolka z ograniczona odpowiedzialnoscia
Olsztyn, 10-165
Uniwersytecki Szpital Kliniczny w Opolu
Opole, 45-401
G and G Medvision Spolka z ograniczona odpowiedzialnoscia
Oświęcim, 32-600
Centrum Zdrowia Metabolicznego Pawel Bogdanski
Poznan, 60-589
Praktyka Lekarska Ewa Krzyzagorska
Poznan, 61-655
Centrum Medyczne Medyk Spolka z Ograniczona Odpowiedzialnoscia Spolka Komandytowa
Rzeszów, 35-055
Nowe Zdrowie-Ck Kieltucki i Wspolnicy Spolka Jawna
Staszów, 28-200
Osrodek Badan Klinicznych Labmed Sp zoo
Szczecin, 71-526
Centrum Szybkiej Diagnostyki Kardiologicznej Kardiomed M Zabowka E Zabowka Spolka cywilna
Tarnów, 33-100
Metabolica Spolka z Ograniczona Odpowiedzialnoscia
Tarnów, 33-100
Praktyka Lekarska Lidia Pawlowicz
Torun, 87-100
Wojewodzki Szpital Zespolony im L Rydygiera w Toruniu
Torun, 87-100
American Heart of Poland Spolka Akcyjna Polsko-Amerykanskie Kliniki Serca
Tychy, 43-100
Futuremeds Spolka z ograniczona odpowiedzialnoscia
Warsaw, 00-215
Clinical Best Solutions Sp zoo Spolka komandytowa
Warsaw, 00-710
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji
Warsaw, 02-507
Szpital Grochowski imienia Doktora medycyny Rafala Masztaka Spzoo
Warsaw, 04-073
Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
Warsaw, 04-635
4 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ we Wroclawiu
Wroclaw, 50-981
Futuremeds spolka z ograniczona odpowiedzialnoscia
Wroclaw, 53-673
Velocity Nova Sp zoo Velocity Zamosc
Zamość, 22-400
Halina Serafin NZOZ Centrum Medyczne "Serafin-Med"
Żarów, 58-130
Brazil37 sites
jmf Clinica do Coracao ltda
Aracaju, Sergipe, 49055-530
Hospital Universitário João de Barros Barreto
Belém, Pará, 66073-005
Santa Casa de Misericordia de Belo Horizonte
Belo Horizonte, Minas Gerais, 30150-221
Ccih - Consultoria em Controle de Infecção Hospitalar
Belo Horizonte, Minas Gerais, 30150-320
Cardresearch Cardiologia Assistencial de Pesquisa
Belo Horizonte, Minas Gerais, 31110-580
Instituto de Ensino e Pesquisa do Hospital do Coracao do Brasil
Brasília, Federal District, 70390-700
Assoc Amparo Saude Ensin e Pesquisa
Brasília, Federal District, 71625-175
Loema Instituto de Pesquisa Clinica e Consultores Ltda - Clinica Loema
Campinas, São Paulo, 13010-001
Instituto de Pesquisa Clinica de Campinas - Ipecc
Campinas, São Paulo, 13060-080
Hospital Universitario Maria Aparecida Pedrossian
Campo Grande, Mato Grosso do Sul, 79080-190
Quanta Diagnostico por Imagem
Curitiba, Paraná, 80045-170
Centro de Pesquisas em Diabetes e Doencas Endocrino Metabolicas
Fortaleza, Ceará, 60430-350
NS Clinica De Endocrinologia E Diabetes - Cendi
Goiânia, Goiás, 74230-035
Hospital das Clinicas da Universidade Federal de Goias
Goiânia, Goiás, 74605-020
Instituto do Coracao de Marilia
Marília, São Paulo, 17515-000
Instituto Atena de Pesquisa Clínica
Natal, Rio Grande do Norte, 59020-500
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90410-000
Nucleo de Pesquisa do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, 90430-001
Hospital Agamenon Magalhaes
Recife, Pernambuco, 52051-380
IBPClin Instituto Brasil de Pesquisa Clinica
Rio de Janeiro, 20241-180
Ruschel Medicina e Pesquisa Clinica
Rio de Janeiro, 22270-060
Hospital Ana Nery
Salvador, Estado de Bahia, 40301-155
Inovace Pesquisa Clinica
Salvador, Estado de Bahia, 40301-155
Praxis Pesquisa Medica
Santo André, São Paulo, 09090-790
Cemec Centro Multidisciplinar Estudos Clinicos
São Bernardo do Campo, São Paulo, 09715-090
Hospital de Base de Sao Jose do Rio Preto
São José do Rio Preto, São Paulo, 15090-000
Ispem - Instituto Sao Jose dos Campos em Pesquisas Medicas
São José dos Campos, São Paulo, 12243-280
Centro de Pesquisas Clinicas Cpclin
São Paulo, São Paulo, 01228-200
Instituto Dante Pazzanese de Cardiologia
São Paulo, São Paulo, 04012-909
Br Trials - Ensaios Clínicos e Consultoria
São Paulo, 01236-030
CPQuali Pesquisa Clinica Ltda
São Paulo, 01240-020
Centro Paulista de Investigacao Clinica Cepic
São Paulo, 04266-010
Instituto do Coracao do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, 05403-000
Instituto de Molestias Cardiovasculares de Tatui
Tatuí, São Paulo, 18270-170
Eurolatino Pesquisas Medicas
Uberlândia, Minas Gerais, 38400-500
Centro do Diagnostico e Pesquisa da Osteoporose do Espirito Santo
Vitória, Espírito Santo, 29055-450
Integral Pesquisa e Ensino
Votuporanga, São Paulo, 15501-405
Spain33 sites
Complexo Hospitalario Universitario A Coruña
A Coruña, Galicia, 15006
Hospital Universitario de La Ribera
Alzira, Valencia, 46600
Hospital Universitario de Badajoz
Badajoz, Extremadura, 06080
Hospital Universitari Germans Trias i Pujol
Badalona, Catalonia, 08916
Hospital Universitari Vall d Hebron
Barcelona, Catalonia, 08035
Hospital Clinic i Provincial de Barcelona
Barcelona, Catalonia, 08036
Hospital Vithas Sevilla
Castilleja de la Cuesta, Andalusia, 41950
Hospital Universitario Reina Sofia
Córdoba, Andalusia, 14004
Hospital Universitario Virgen de la Arrixaca
El Palmar, Murcia, 30120
Complexo Hospitalario Universitario de Ferrol Hospital Universitario Arquitecto Marcide
Ferrol, Galicia, 15405
Complejo Hospitalario de Jaen
Jaén, Andalusia, 23007
Hospital Universitario de Leon
León, 24008
FutureMeds Madrid
Madrid, 28003
Hospital General Universitario Gregorio Marañon
Madrid, 28007
Hospital Universitario Sanitas la Zarzuela
Madrid, 28023
Hospital Universitario Ramon y Cajal
Madrid, 28034
Hospital Clinico San Carlos
Madrid, 28040
Hospital QuironSalud Malaga
Málaga, Andalusia, 29004
Hospital Clinico Universitario Virgen de la Victoria
Málaga, Andalusia, 29010
Hospital Regional Universitario de Malaga
Málaga, Andalusia, 29011
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, 33011
Hospital de Navarra
Pamplona, Navarre, 31008
Hospital Quiron Madrid
Pozuelo de Alarcón, Madrid, 28223
Hospital Universitari Sant Joan de Reus
Reus, Catalonia, 43204
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Canary Islands, 38320
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, 39008
Hospital Clinico Universitario de Santiago
Santiago de Compostela, Galicia, 15706
Nuevas Tecnologias en Diabetes y Endocrinologia
Seville, Andalusia, 41003
Hospital Universitario Virgen del Rocio
Seville, Andalusia, 41013
Hospital Quironsalud Infanta Luisa
Seville, 41010
Hospital Clinico Universitario de Valencia
Valencia, Valencia, 46010
Hospital Universitario Doctor Peset
Valencia, 46017
Hospital Alvaro Cunqueiro
Vigo, Galicia, 36312
Hungary32 sites
Lausmed Kft
Baja, 6500
DRC Gyogyszervizsgalo Kozpont Kft
Balatonfüred, 8230
Tagore Medical Center
Balatonfüred, 8230
Dr Lakatos Ferenc Private Cardiology Practice
Békéscsaba, 5600
Trial Pharma Kft
Budapest, 1023
Clinexpert Kft
Budapest, 1033
Obudai Egeszsegugyi Centrum Kft
Budapest, 1036
PVN Kutato Kft
Budapest, 1102
Semmelweis Egyetem Varosmajori Sziv- es Ergyogyaszati Klinika
Budapest, 1122
Eszak-Pesti Centrum Korhaz - Honvedkorhaz
Budapest, 1134
MedKontroll Egeszsegkozpont
Budapest, 1134
Budapesti Uzsoki Utcai Korhaz
Budapest, 1145
Strazsahegy Medicina Bt
Budapest, 1171
Borvo Clinic Kft
Debrecen, 4025
Debreceni Egyetem Klinikai Kozpont
Debrecen, 4032
Obudai Egeszsegugyi Centrum Kft
Dunaújváros, 2400
CRU Hungary Kft
Encs, 3860
Gyongyosi Bugat Pal Korhaz
Gyöngyös, 3200
BKS Research Kft
Hatvan, 3000
Obudai Egeszsegugyi Centrum Kft
Kaposvár, 7400
Trial Pharma Kft
Kecskemét, 6000
Komaromi Selye Janos Korhaz
Komárom, 2921
Borsod-Abauj-Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktatokorhaz
Miskolc, 3526
IPR Hungary Kft
Miskolc, 3530
Borbanya Praxis Egeszsegugyi Kft
Nyíregyháza, 4405
Dr Nagy Laszlo Kardiologiai maganrendeles es SMO
Orosháza, 5900
COROMED-SMO Kft
Pécs, 7623
DaVinci Maganklinika
Pécs, 7635
KomplexLabor Diagnosztika Kft
Szeged, 6724
Complex Rendelo Med Zrt
Székesfehérvár, 8000
Vas-Oxy Kft
Szombathely, 9700
Obudai Egeszsegugyi Centrum Kft
Zalaegerszeg, 8900
Japan32 sites
Chiba University Hospital
Chiba, Chiba, 260-8677
Medical Corporation Kenshinkai Minamino Cardiovascular Hospital
Hachioji-shi, Tokyo, 192-0918
Japanese Red Cross Hamamatsu Hospital
Hamamatsu, Shizuoka, 434-8533
Affiliated Central Clinic of Higashiyamato Hospital
Higashiyamato-shi, Tokyo, 207-0014
Teikyo University Hospital
Itabashi-ku, Tokyo, 173-8606
Tenyoukai Central Clinic
Kagoshima, Kagoshima-ken, 892-0822
Ishikawa Prefectural Central Hospital
Kanazawa, Ishikawa-ken, 920-8530
National Hospital Organization Kanazawa Medical Center
Kanazawa, Ishikawa-ken, 920-8650
Kumamoto University Hospital
Kumamoto, Kumamoto, 860-8556
Rakuwakai Otowa Hospital
Kyoto, Kyoto, 607-8062
Tokyo Saiseikai Central Hospital
Minato-ku, Tokyo, 108-0073
Miyazaki Medical Association Hospital
Miyazaki, Miyazaki, 880-2102
Chubu Rosai Hospital
Nagoya, Aichi-ken, 455-8530
Nakakinen Clinic
Naka, Ibaraki, 311-0113
Oita Red Cross Hospital
Ōita, Oita Prefecture, 870-0033
Okayama Rosai Hospital
Okayama, Okayama-ken, 702-8055
Miyanosawa Clinic of Internal Medicine and Cardiology
Sapporo, Hokkaido, 063-0826
Medical corporation Sekishin-kai Saitama Sekishinkai Hospital
Sayama-shi, Saitama, 350-1305
Sayama Renal Clinic
Sayama-shi, Saitama, 350-1305
KKR Tohoku Kosai Hospital
Sendai, Miyagi, 980-0803
Tokuyama Central Hospital
Shunan-shi, Yamaguchi, 745-8522
NewHeart Watanabe Institute
Suginami-ku, Tokyo, 168-0065
Saiseikai Senri Hospital
Suita-shi, Osaka, 565-0862
Takamatsu Red Cross Hospital
Takamatsu, Kagawa-ken, 760-0017
Kagawa Prefectural Central Hospital
Takamatsu, Kagawa-ken, 760-8557
JA Toride Medical Center
Toride-shi, Ibaraki, 302-0022
Fujita Health University Hospital
Toyoake-shi, Aichi-ken, 470-1192
Tsuchiura Kyodo General Hospital
Tsuchiura-shi, Ibaraki, 300-0028
Urasoe General Hospital
Urasoe-shi, Okinawa, 901-2102
Saiseikai Yokohamashi Tobu Hospital
Yokohama, Kanagawa, 230-8765
Yokohama Minami Kyousai Hospital
Yokohama, Kanagawa, 236-0037
Sanin Rosai Hospital
Yonago-shi, Tottori, 683-8605
Netherlands31 sites
Noordwest Ziekenhuisgroep
Alkmaar, 1815 JD
Ziekenhuisgroep Twente
Almelo, 7609 PP
EB Medical Research
Almere Stad, 1311 RL
Meander Medisch Centrum
Amersfoort, 3813 TZ
Ziekenhuis Amstelland
Amstelveen, 1186 AM
Onze Lieve Vrouwe Gasthuis
Amsterdam, 1091 AC
Amsterdam Universitair Medisch Centrum
Amsterdam, 1105 AZ
Gelre Ziekenhuizen
Apeldoorn, 7334 DZ
Rijnstate Ziekenhuis
Arnhem, 6815 AD
Amphia ziekenhuis
Breda, 4818 CK
Reinier de Graaf Gasthuis
Delft, 2625 AD
Deventer Ziekenhuis
Deventer, 7416 SE
Slingeland Ziekenhuis
Doetinchem, 7009 BL
Albert Schweitzer Ziekenhuis location Dordwijk
Dordrecht, 3318 AT
Albert Schweitzer Ziekenhuis, Locatie Dordwijk
Dordrecht, 3318 AT
Catharina Ziekenhuis
Eindhoven, 5623 EJ
Spaarne Gasthuis, locatie Haarlem Zuid
Haarlem, 2035 RC
Sint Jansdal Ziekenhuis
Harderwijk, 3844 DG
Elkerliek Ziekenhuis
Helmond, 5707 HA
Tergooiziekenhuizen, locatie Hilversum
Hilversum, 1213 XZ
Bethesda Diabetes Research Center
Hoogeveen, 7909 AA
Frisius Medisch Centrum, locatie Leeuwarden
Leeuwarden, 8934 AD
Leids Universitair Medisch Centrum
Leiden, 2333 ZA
Radboud Universitair Medisch Centrum
Nijmegen, 6525 GA
Erasmus Medisch Centrum
Rotterdam, 3015 GD
Ikazia Ziekenhuis
Rotterdam, 3083 AN
D and A Research and Genetics
Sneek, 8601 ZR
Haga Ziekenhuis
The Hague, 2545 AA
Ziekenhuis Rivierenland
Tiel, 4002 WP
Universitair Medisch Centrum Utrecht
Utrecht, 3584 CX
VieCuri Medisch Centrum
Venlo, 5912 BL
Argentina30 sites
Centro Medico Viamonte
CABA, Buenos Aires, 1120
Imoba Investigaciones medicas
CABA, Buenos Aires, 1178
Conexa Investigacion Clinica SA
CABA, Buenos Aires, C1012AAY
Stat Research
CABA, Buenos Aires, C1023AAB
Cedic - Centro de Investigacion Clinica
CABA, Buenos Aires, C1060ABN
Cemedic Centro de Especialidades Medicas
CABA, Buenos Aires, C1407GTN
Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada
CABA, Buenos Aires, C1425AGC
Consultorios Medicos Dr Besada
CABA, Buenos Aires, C1426ABP
Fundacion Respirar - Consultorios Medicos Dr Doreski
CABA, Buenos Aires, C1426ABP
Glenny Corp SA
CABA, Buenos Aires, C1430CKE
Centro Medico de Nutricion y Diabetes
CABA, C1440AAD
Cinme - Centro de Investigaciones Metabolicas
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1056ABI
Ciprec - Centro de Investigacion y Prevencion Cardiovascular
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1061AAT
Centro Diabetologico Dr Waitman
Córdoba, Córdoba Province, 5000
Clinica Privada del Prado
Córdoba, Córdoba Province, 5000
Instituto Medico Damic
Córdoba, X5003DCE
CIPADi
Godoy Cruz, Mendoza Province, M5501ARP
Hospital Italiano de La Plata
La Plata, Buenos Aires, B1900AUR
Centro de Investigaciones Medicas Mar del Plata
Mar del Plata, Buenos Aires, B7600DHK
Instituto de Investigaciones clinicas de Mar del Plata
Mar del Plata, Buenos Aires, B7600FZN
Dim Clinica Privada
Ramos Meija, Buenos Aires, B1704ETD
Instituto Medico Rio Cuarto SA
Río Cuarto, Córdoba Province, X5800AEV
Instituto Medico Catamarca Imec
Rosario, Santa Fe Province, S2000AJU
INECO Neurociencias Oronio
Rosario, S2000DSR
Instituto de Investigaciones Clinicas de San Nicolas
San Nicolás de los Arroyos, Buenos Aires, 2900
Centro de Investigaciones Clinicas del Litoral
Santa Fe, S3000FWO
mit - Medicina Investigacion y Tratamiento
Santa Rosa, La Pampa Province, L6304BWE
Clinica Fusavim Privada SRL
Villa María, Córdoba Province, 5900
Go Centro Medico San Nicolas
Zárate, Buenos Aires, B2800DGH
Instituto de Investigaciones Clinicas Zarate
Zárate, Buenos Aires, B2800DGH
United Kingdom28 sites
Heartlands Hospital
Birmingham, B9 5SS
Waterloo Medical Centre
Blackpool, FY4 3AD
Southmead Hospital
Bristol, BS10 5NB
West Walk Surgery
Bristol, BS37 4AX
Addenbrookes Hospital
Cambridge, CB2 0QQ
Countess of Chester Hospital
Chester, CH2 1UL
University Hospital Coventry
Coventry, CV2 2DX
Russell Hall Hospital
Dudley, DY1 2HQ
Ninewells Hospital and Medical School
Dundee, DD1 9SY
Staploe Medical Centre
Ely, CB7 5JD
Royal Devon and Exeter Hospital
Exeter, EX2 5DW
Glasgow Royal Infirmary
Glasgow, G31 2ER
Wycombe Hospital
High Wycombe, HP11 2TT
Hull Royal Infirmary
Hull, HU3 2JZ
Glenfield Hospital
Leicester, LE3 9QP
Queen Mary University of London
London, EC1M 6BQ
Chelsea and Westminster Hospital
London, SW10 9NH
St Georges Hospital
London, SW17 0QT
Northenden Group Practice
Manchester, M22 4DH
Newcastle NIHR Commercial Research Delivery Centre
Newcastle upon Tyne, NE1 4LP
University Hospital Llandough
Penarth, CF64 2XX
Salford Royal Hospital
Salford, M5 5AP
Lister Hospital
Stevenage, SG1 4AB
Morriston Hospital
Swansea, SA2 8PP
Musgrove Park Hospital
Taunton, TA1 5DA
Torbay Hospital
Torquay, TQ2 7AA
Bradford on Avon and Melksham Health Partnership
Wiltshire, BA15 1DQ
Worcestershire Royal Hospital
Worcester, WR5 1DD
Slovakia20 sites
Alian, sro
Bardejov, 085 01
Dia-Clarus, sro
Bojnice, 972 01
MediTask, sro
Bratislava, 831 03
Novate sro
Bratislava, 841 04
Medispektrum sro
Bratislava, 851 01
Medical group Kosice sro
Košice, 040 01
Cardio D and R, sro Kosice
Košice, 040 22
Kardio 1 sro
Lučenec, 984 01
MediVet, sro
Malacky, 901 01
Poliklinika Nemocnicna as
Malacky, 901 22
Nemocnica s poliklinikou Stefana Kukuru Michalovce, as
Michalovce, 071 01
Oralek, sro
Námestovo, 029 01
InterStom, sro
Nitra, 949 11
Funkystuff sro
Nové Zámky, 940 02
Intermedis sro
Prešov, 080 01
Medispol, sro
Prešov, 080 01
Tatratrial sro
Rožňava, 048 01
Medi-Dia sro
Sabinov, 083 01
Interna SK, sro
Svidník, 089 01
Pentes, sro
Žilina, 010 01
Turkey (Türkiye)20 sites
Yuregir Baskent Hastanesi
Adana, 01250
Adana Sehir Egitim ve Arastirma Hastanesi
Adana, 01370
Afyonkarahisar Saglik Bilimleri Universitesi Hastanesi
Afyonkarahisar, 03218
Ankara Bilkent Sehir Hastanesi
Ankara, 06800
Akdeniz Universitesi Tip Fakultesi
Antalya, 07058
Bursa Yuksek Ihtisas Egitim ve Arastirma Hastanesi
Bursa, 16310
Pamukkale Universitesi Tip Fakultesi Hastanesi
Denizli, 20160
Koc Universitesi Hastanesi
Istanbul, 34010
Istanbul Universitesi Cerrahpasa Tip Fakultesi
Istanbul, 34096
Bagcilar Medipol Mega Universite Hastanesi
Istanbul, 34214
Sultangazi Haseki Egitim ve Arastirma Hastanesi
Istanbul, 34265
Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi
Istanbul, 34303
Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi
Istanbul, 34722
Marmara Universitesi Tip Fakultesi Pendik Egitim ve Arastirma Hastanesi
Istanbul, 34854
Ege Universitesi Tip Fakultesi Hastanesi
Izmir, 35100
Izmir Sehir Hastanesi
Izmir, 35540
Erciyes Universitesi Tip Fakultesi Hastanesi
Kayseri, 38039
Kocaeli Universitesi Tip Fakultesi Hastanesi
Kocaeli, 41380
Inonu Universitesi Turgut Ozal Tip Merkezi
Malatya, 44280
Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi
Samsun, 55320
Australia18 sites
Advara HeartCare Wesley
Auchenflower, Queensland, 4066
Flinders Medical Centre
Bedford Park, South Australia, 5042
Novatrials
Charlestown, New South Wales, 2290
Victorian Heart Hospital
Clayton, Victoria, 3168
Momentum Clinical Research - Darlinghurst
Darlinghurst, New South Wales, 2010
Barwon Health Geelong Hospital
Geelong, Victoria, 3220
Austin Health, Heidelberg Repatriation Hospital
Heidelberg West, Victoria, 3081
Royal Brisbane and Womens Hospital
Herston, Queensland, 4029
Advara HeartCare Joondalup
Joondalup, Western Australia, 6027
Advara HeartCare Leabrook
Leabrook, South Australia, 5068
The Alfred Hospital
Melbourne, Victoria, 3004
Core Research Group Pty Ltd
Milton, Queensland, 4064
Advara HeartCare Mulgrave
Mulgrave, Victoria, 3170
Fiona Stanley Hospital
Murdoch, Western Australia, 6150
Linear Clinical Research Limited
Nedlands, Western Australia, 6009
Royal North Shore Hospital
St Leonards, New South Wales, 2065
The Queen Elizabeth Hospital
Woodville South, South Australia, 5011
Dr Heart Pty Ltd
Woolloongabba, Queensland, 4102
Canada17 sites
Centricity Research Brampton
Brampton, Ontario, L6S 0C6
Aggarwal and Associates Ltd
Brampton, Ontario, L6T 0G1
Cambridge Cardiac Care Centre
Cambridge, Ontario, N1R 6V6
Ecogene-21
Chicoutimi, Quebec, G7H 7K9
Janek Senaratne Professional Medical Corporation
Edmonton, Alberta, T6K 4C1
G A Research Associates Limited
Moncton, New Brunswick, E1G 1A7
Montreal Heart Institute
Montreal, Quebec, H1T 1C8
Centre de Recherche du Centre Hospitalier de l Universite de Montreal
Montreal, Quebec, H2X 0C1
Research Institute of McGill University Health Center - Glen Site
Montreal, Quebec, H4A 3J1
North York Diagnostic and Cardiac Centre
North York, Ontario, M6B 3H7
Institut Universitaire de cardiologie et de pneumologie de Quebec
Québec, Quebec, G1V 4G5
Centre intégré de santé et service sociaux de Lanaudière
Saint-Charles-Borromée, Quebec, J6E 6J2
Heart Health Institute Research Incorporated
Scarborough Village, Ontario, M1B 4Z8
KMH Cardiology Centres Incorporated Hamilton
Stoney Creek, Ontario, L8J 3W2
Diabetes Heart Research Centre
Toronto, Ontario, M6G 1M2
Vancouver General Hospital, Gordon and Leslie Diamond Health Care Centre
Vancouver, British Columbia, V5Z 1M9
Discovery Clinical Services Ltd
Victoria, British Columbia, V8T 5G4
France16 sites
Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz
Besançon, 25030
Centre Hospitalier Universitaire de Dijon - Hopital Francois Mitterrand
Dijon, 21079
Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon
Grenoble, 38700
Centre Hospitalier Louis Pasteur
Le Coudray, 28630
Hopital le Creusot
Le Creusot, 71200
Centre Hospitalier Saint Joseph Saint Luc
Lyon, 69007
Hopital de la Conception
Marseille, 13005
Centre Hospitalier Universitaire de Nice - Hopital Pasteur
Nice, 06000
Hopital Europeen Georges Pompidou
Paris, 75015
Hopital Bichat Claude Bernard
Paris, 75018
Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque
Pessac, 33604
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495
Centre Hospitalier Regional Universitaire de Strasbourg - Hopital de Hautepierre
Strasbourg, 67000
Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil
Toulouse, 31059
Polyclinique Vauban
Valenciennes, 59300
Centre Hospitalier Universitaire de Nancy - Hopital de Brabois
Vandœuvre-lès-Nancy, 54511
Romania15 sites
Cardioplus Center SRL
Baia Mare, 430124
cmi Pop Lavinia
Baia Mare, 430222
Mariodiab Clinic SRL
Brasov, 500101
Thera Card SRL
Brasov, 500102
Centrul Medical de Diagnostic si Tratament Ambulator Neomed
Brasov, 500283
Geea Medical Easy Diet
Bucharest, 010627
Centrul pentru Studiul Metabolismului - Hightech Medical Services SRL
Bucharest, 011053
Institutul National de Diabet si Nutritie si Boli Metabolice N C Paulescu
Bucharest, 030167
Spitalul Universitar de Urgenta Bucuresti
Bucharest, 050098
Milena Sante
Galati, 800001
Consultmed SRL
Iași, 700544
Diabdana SRL
Oradea, 410147
Clinica Korall
Satu Mare, 440055
Mediab SRL
Târgu Mureş, 540142
Cabinet Medical Individual Dr Podoleanu Cristian
Târgu Mureş, 540143
Greece14 sites
University Hospital of Alexandroupolis
Alexandroupoli, 68100
Athens Naval Hospital
Athens, 11521
General Hospital for Thoracic Diseases of Athens "Sotiria"
Athens, 11527
General Hospital for Thoracic Diseases of Athens "Sotiria
Athens, 11527
General Hospital of Athens Ippokrateio
Athens, 11527
General Hospital of Athens Laiko
Athens, 11527
Alexandra Hospital
Athens, 11528
University General Hospital Attikon General Hospital Of West Attica H Agia Varvara
Athens, 12462
Hygeia Hospital
Athens, 15123
General Hospital Asklipieio Voulas
Athens, 16673
University Hospital of Ioannina
Ioannina, 45500
Ahepa University Hospital
Thessaloniki, 54636
University General Hospital of Thessaloniki Ahepa
Thessaloniki, 54636
Papageorgiou General Hospital of Thessaloniki
Thessaloniki, 56403
South Korea14 sites
Daegu Catholic University Medical Center
Daegu, 42472
Keimyung University Dongsan Medical Center
Daegu, 42601
Myongji Hospital
Goyang-si, Gyeonggi-do, 10475
Gachon University Gil Medical Center
Incheon, 21565
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620
Kyung Hee University Hospital
Seoul, 02447
Korea University Anam Hospital
Seoul, 02841
Seoul National University Hospital
Seoul, 03080
Kangbuk Samsung Hospital
Seoul, 03181
Severance Hospital Yonsei University Health System
Seoul, 03722
Kyung Hee University Hospital at Gangdong
Seoul, 05278
The Catholic University of Korea Seoul St Marys Hospital
Seoul, 06591
Ulsan University Hospital
Ulsan, 44033
Yonsei University Wonju Severance Christian Hospital
Wonju-si, Gangwon-do, 26426
Denmark13 sites
Aalborg Universitetshospital
Aalborg, 9000
Aarhus Universitetshospital
Aarhus N, 8200
Esbjerg sygehus Syddansk universitetshospital
Esbjerg, 6700
Sanos Gandrup
Gandrup, DK-9362
Steno Diabetes Center Copenhagen
Herlev, 2730
Regionshospitalet Gødstrup
Herning, 7400
Holbaek Sygehus
Holbæk, 4300
Hvidovre Hospital
Hvidovre, 2650
Frederiksberg Hospital
København NV, 2400
Amager Hospital
København S, 2300
Sjaellands Universitetshospital, Roskilde
Roskilde, 4000
Svendborg Sygehus
Svendborg, 5700
Sanos Vejle
Vejle, 7100
Italy13 sites
Azienda Unita Locale Socio Sanitaria Berica 8 Ospedale Cazzavillan
Arzignano, 36071
Azienda Ospedaliera Sant Anna e San Sebastiano
Caserta, 81100
Casa della salute Ceccano Ospedale
Ceccano, 03023
Ospedale Santissima Annunziata
Chieti, 66100
Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia
Foggia, 71122
Azienda Sanitaria Locale Abruzzo 1 Avezzano, Sulmona e L'Aquila - Ospedale regionale San Salvatore
L’Aquila, 67100
IRCCS Ospedale San Raffaele
Milan, 20132
IRCCS Centro Cardiologico Monzino
Milan, 20138
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Milan, 20162
Azienda Ospedale - Università Padova
Padova, 35128
Azienda Unita Sanitaria Locale Romagna
Rimini, 47923
Policlinico Universitario Campus Biomedico
Roma, 00128
Azienda Ospedaliera Ordine Mauriziano di Torino
Torino, 10128
Belgium12 sites
Azorg Campus Aalst - Moorselbaan
Aalst, 9300
Imelda Ziekenhuis vzw
Bonheiden, 2820
Algemeen Ziekenhuis Sint-Jan Brugge
Bruges, 8000
Cliniques universitaires de Bruxelles Hopital Erasme
Brussels, 1070
Universitair Ziekenhuis Antwerpen
Edegem, 2650
Ziekenhuis Oost-Limburg - Campus Sint-Jan
Genk, 3600
Algemeen Ziekenhuis Sint Lucas
Ghent, 9000
Centres Hospitaliers Universitaires - Helora - Hopital de La Louviere - Site Jolimont
La Louvière, 7100
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, 3000
Centre Hospitalier Universitaire de Liege - Sart Tilman
Liège, 4000
AZ Oostende - Damiaan
Ostend, 8400
Universite Catholique de Louvain Cliniques Universitaires de Mont-Godinne
Yvoir, 5530
Mexico11 sites
Centro Medico Nacional Siglo XXI
Cuauhtémoc, 06720
Instituto de Diabetes Obesidad y Nutricion
Cuernavaca, Morelos, 62250
Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC
Culiacán, Sinaloa, 80230
Private Practice Dr. Francisco Padilla Padilla
Guadalajara, Jalisco, 44670
Medical Care and Research Sociedad Anonima
Mérida, Yucatán, 97070
Soluciones Terapeuticas Medico Quirurgicas
Mexico City, Mexico City, 03650
Cardiolink Clin Trials
Monterrey, Nuevo León, 64060
Unidad Biomedica Avanzada Monterrey
Monterrey, Nuevo León, 64460
Centro de Estudios Clinicos de Queretaro
Querétaro, 76000
Centro de Estudios de Investigacion Metabolicos y Cardiovasculares SC
Tampico, Tamaulipas, 89000
Sociedad de Metabolismo y Corazon
Veracruz, 91855
Bulgaria10 sites
Multiprofile Hospital for Active Treatment Puls AD
Blagoevgrad, 2700
Medical Center Doctor Staikov EOOD
Burgas, 8008
Medical Center Medconsult Pleven OOD
Pleven, 5800
Multiprofile Hospital for Active Treatment Heart and Brain EAD
Pleven, 5804
Multiprofile Hospital for Active Treatment Sveta Karidad EAD
Plovdiv, 4004
National Multiprofile Transport Hospital Tzar Boris III
Sofia, 1233
University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD
Sofia, 1527
Military Medical Academy - Multiprofile Hospital for Active Treatment Sofia
Sofia, 1606
University Multiprofile Hospital for Active Treatment and Emergency Medicine N I Pirogov EAD
Sofia, 1606
Medical Center Dr Kalchev OOD
Sofia, 1700
Portugal10 sites
Unidade Local de Saude de Braga, EPE
Braga, 4710-243
Unidade Local de Saude de Lisboa Ocidental, EPE - Hospital de Santa Cruz
Carnaxide, 2790-134
Unidade Local de Saude de Coimbra, EPE
Coimbra, 3000-075
Unidade Local de Saude do Alto Ave, EPE
Guimarães, 4835-044
Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria
Lisbon, 1649-035
Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano
Matosinhos Municipality, 4464-513
Cardiolima - Centro de Diagnóstico Cardiopulmonar
Ponte de Lima, 4990-029
Ucardio - Centro Clinico Cardiovascular
Riachos, Torres Novas, 2350-325
Unidade Local de Saude de Entre Douro e Vouga, EPE - Hospital de Sao Sebastiao
Santa Maria da Feira, 4520-211
Unidade Local de Saude de Gaia-Espinho, EPE
Vila Nova de Gaia, 4430-502
Austria9 sites
Landeskrankenhaus Feldkirch
Feldkirch, 6800
Medizinische Universitaet Graz
Graz, 8036
Klinikum Klagenfurt am Woerthersee
Klagenfurt, 9020
Krankenhaus der Barmherzigen Brueder Linz
Linz, 4021
CardioMetabolicCentre
Mattersburg, 7210
Klinik Landstrasse
Vienna, 1030
Zentrum fuer klinische Studien - Dr Hanusch GmbH
Vienna, 1060
Universitaetsklinikum Allgemeines Krankenhaus Wien
Vienna, 1090
Klinik Hietzing
Vienna, 1130
Taiwan8 sites
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 80756
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301
Taichung Veterans General Hospital
Taichung, 40705
National Taiwan University Hospital
Taipei, 10002
Taipei Medical University Hospital
Taipei, 11031
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, 11101
Taipei Veterans General Hospital
Taipei, 11217
Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation
Taoyuan, 33305
Chile7 sites
Fundacion Innovacion Cardiovascular Clinica Ensenada
Independencia, Santiago Metropolitan
Enroll SpA
Providencia, Santiago Metropolitan, 7500587
Biocinetic servicios medicos limitada
Santiago, 8320000
Hospital Las Higueras
Talcahuano, Biobio, 4260000
Centro de Investigacion Clinica del Sur
Temuco, Cautín, 4781156
Clinical Research Chile SpA
Valdivia, 5110683
Cinvec Estudios Clinicos quinta region Limitada
Viña del Mar, Valparaiso, 2520997
Sweden7 sites
Falu Lasarett
Falun, 791 82
Sahlgrenska Universitetssjukhus
Gothenburg, 413 45
Helsingborgs Lasarett
Helsingborg, 251 87
Linkopings Universitetssjukhus
Linköping, 581 85
Clemenstorgets Hjartmottagning
Lund, 222 21
Orebros Universitetssjukhus
Örebro, 703 62
Karolinska Universitetssjukhuset Solna
Stockholm, 171 64
Colombia6 sites
Institucion Prestadora de Salud Centro Científico Asistencia
Barranquilla, Atlántico, 080002
Fundacion del Caribe para la Investigacion Biomedica
Barranquilla, Atlántico, 080020
Salud Sura Calle 100
Bogota, Cundinamarca, 110231
Rodrigo Botero SAS
Medellín, Antioquia, 050012
Instituto Cardiovascular del Cesa SA Cardiocesar
Valledupar, Cesar Department, 200001
Healthy Medical Center sas
Zipaquirá, Cundinamarca, 250251
Finland6 sites
Helsinki University Hospital
Helsinki, 000290
Helsinki University Hospital
Helsinki, 00029
Studycor Oy
Jyväskylä, 40620
Health Step Finland
Kuopio, 70600
Oulu University Hospital
OYS, 90029
Tays sydankeskus oy
Tampere, 33520
Singapore6 sites
Ng Teng Fong General Hospital
Singapore, Jurong East, 609606
Sengkang General Hospital
Singapore, Sengkang, 544886
National University Hospital
Singapore, 119074
National Heart Centre Singapore
Singapore, 169609
Tan Tock Seng Hospital
Singapore, 308433
Changi General Hospital
Singapore, 529889
Switzerland6 sites
Universitaetsspital Basel
Basel, 4031
Inselspital Bern
Bern, 3010
Hopitaux Universitaires de Geneve
Geneva, 1211
Centre hospitalier universitaire vaudois
Lausanne, 1011
Istituto Cardiocentro Ticino
Lugano, 6900
Universitaetsspital Zuerich
Zurich, 8091
Hong Kong2 sites
Queen Mary Hospital, The University of Hong Kong
Hong Kong
Prince of Wales Hospital, Chinese University of Hong Kong
Shatin, New Territories
About this study
Official title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.
- Conditions
- Atherosclerotic Cardiovascular Disease, Overweight, Obesity
- Being tested
- Maridebart Cafraglutide, Placebo
- Keywords
- Atherosclerotic Cardiovascular Disease, Overweight, Obesity, Maridebart cafraglutide, AMG 133, MariTide
- Medical subject headings
- Atherosclerosis, Overweight, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Maridebart CafraglutideDrug
Also called AMG 133, MariTide
Maridebart cafraglutide will be administered SC.
PlaceboDrug
Placebo will be administered SC.
| Study group | Role | What they receive |
|---|---|---|
| Maridebart Cafraglutide | Experimental | Participants will receive maridebart cafraglutide subcutaneously (SC). Receives: Drug: Maridebart Cafraglutide |
| Placebo | Placebo comparator | Participants will receive placebo SC. Receives: Drug: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, Myocardial Infarction (MI), or Ischemic Stroke (3-point Major Adverse Cardiac Events [3-P MACE])
Measured: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of: All-cause Death, MI, Ischemic Stroke, Coronary Revascularization, or Heart Failure (HF) Event (5-point MACE)
Measured: Up to approximately 35 months
Secondary outcomes (48)
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, MI, Ischemic Stroke, or HF Event
Measured: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, MI, Ischemic Stroke or Coronary Revascularization
Measured: Up to approximately 35 months
Time to First MI
Measured: Up to approximately 35 months
Time to First Ischemic Stroke
Measured: Up to approximately 35 months
Time to CV Death
Measured: Up to approximately 35 months
Time to All-cause Death
Measured: Up to approximately 35 months
Time to First Coronary Revascularization
Measured: Up to approximately 35 months
Time to First HF Event
Measured: Up to approximately 35 months
Time to First HF Event or CV Death
Measured: Up to approximately 35 months
Time to First Unstable Angina Requiring Hospitalization
Measured: Up to approximately 35 months
Time to First Occurrence of MI or CV Death
Measured: Up to approximately 35 months
Time to First Occurrence of MI, Ischemic Stroke or All-cause Death
Measured: Up to approximately 35 months
Total Major Ischemic Events (Time to First and Recurrent MI or Ischemic Stroke)
Measured: Up to approximately 35 months
Total All-cause Hospitalizations (Time to First and Recurrent Event)
Measured: Up to approximately 35 months
Time to Onset of Type 2 Diabetes Mellitus (T2DM) in Participants with Prediabetes at Baseline
Measured: Up to approximately 35 months
Time to Onset of T2DM in Participants without T2DM at Baseline
Measured: Up to approximately 35 months
Change from Baseline in Systolic Blood Pressure (SBP) at Week 72
Measured: Baseline and Week 72
Change from Baseline in Diastolic Blood Pressure (DBP) at Week 72
Measured: Baseline and Week 72
Change from Baseline in Body Mass Index (BMI) at Week 72
Measured: Baseline and Week 72
Change from Baseline in Waist Circumference at Week 72
Measured: Baseline and Week 72
Change from Baseline in Urine Albumin-to-creatinine Ratio (uACR) at Week 72
Measured: Baseline and Week 72
Change from Baseline in Hemoglobin A1c (HbA1c) at Week 72
Measured: Baseline and Week 72
Change from Baseline in Fasting Plasma Glucose at Week 72
Measured: Baseline and Week 72
Percent Change from Baseline in High-sensitivity C-reactive protein (hs-CRP) at Week 72
Measured: Baseline and Week 72
Percent Change from Baseline in Body Weight at Week 72
Measured: Baseline and Week 72
Percent Change from Baseline in Total Cholesterol at Week 72
Measured: Baseline and Week 72
Percent Change from Baseline in High-density Lipoprotein Cholesterol (HDL-C) at Week 72
Measured: Baseline and Week 72
Percent Change from Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Week 72
Measured: Baseline and Week 72
Percent Change from Baseline in Triglycerides (TG) at Week 72
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.5% (48 mmol/mol) in Participants with T2DM at Baseline
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.0% (42 mmol/mol) in Participants with T2DM at Baseline
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 5.7% (39 mmol/mol) in Participants with T2DM at Baseline
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.5% (48 mmol/mol) in Participants Without T2DM at Baseline
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.0% (42 mmol/mol) in Participants Without T2DM at Baseline
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 5.7% (39 mmol/mol) in Participants Without T2DM at Baseline
Measured: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 5.7% (39 mmol/mol) in Participants with HbA1c ≥ 5.7% and < 6.5% at Baseline
Measured: Baseline and Week 72
Change from Baseline in Short Form 36 Health Survey Acute Version 2 (SF-36 v2) Physical Function Domain Score at Week 48
Measured: Baseline and Week 48
Time to First Event of a Composite Nephropathy Endpoint
Composite endpoint consists of onset of persistent macroalbuminuria, persistent ≥ 40% reduction in estimated glomerular filtration rate (eGFR), onset of persistent eGFR < 15 mL/min/1.73 m^2, initiation of chronic renal replacement therapy (dialysis or transplantation), CV or renal death.
Measured: Up to approximately 35 months
Change in eGFR (total slope) for the period from baseline to the final follow up visit
Measured: Baseline up to approximately 35 months
Change in eGFR (chronic slope) for the period from 4 months to the final follow-up visit
Measured: From 4 months up to approximately 35 months
Time to First Occurrence of a Major Adverse Limb Event (MALE) Defined as Acute Limb Ischemia, Urgent Peripheral Revascularization, Major Amputation Due to a Vascular Etiology or Chronic Limb-threatening Ischemia Requiring Revascularization
Measured: Up to approximately 35 months
Total Arterial (Coronary, Cerebrovascular, and Peripheral) Revascularization Procedures (Time to First and Recurrent Event)
Measured: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, MI, Ischemic Stroke, MALE, or Arterial Revascularization
Measured: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, MI, Ischemic Stroke, or Acute Limb Ischemia
Measured: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of CV Death, MI, Ischemic Stroke, Acute Limb Ischemia, or Urgent Arterial Revascularization Procedure (Coronary, Cerebrovascular or Peripheral)
Measured: Up to approximately 35 months
Number of Participants with Treatment-emergent Adverse Events
Measured: Up to approximately 35 months
Number of Participants with Serious Adverse Events
Measured: Up to approximately 35 months
Plasma Concentration of Maridebart Cafraglutide at Week 72
Measured: Week 72
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jun 2025
- Study start25 Jul 2025
- Primary completion30 Jun 2028 (estimated)
- Study completion29 Sep 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atherosclerotic Cardiovascular DiseaseStudies of the same condition, open and under way.
- More trials run by AmgenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 12,800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Amgen
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- MD, Study director, Amgen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07037433
- Sponsor's protocol ID
- 20220196
- Acronym
- MARITIME-CV
- Status last verified
- Oct 2026
- First submitted
- 16 Jun 2025
- Last updated
- 29 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- ClinicalTrials.gov ID
- NCT07037433
- Acronym / sponsor ID
- MARITIME-CV / 20220196
- Conditions
- Atherosclerotic Cardiovascular Disease, Overweight, Obesity
- Keywords
- Atherosclerotic Cardiovascular Disease, Overweight, Obesity, Maridebart cafraglutide, AMG 133, MariTide
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 12,800 participants (estimated)
- Lead sponsor
- AmgenIndustry (pharma, biotech, devices)
- Study start
- 25 Jul 2025 (actual)
- Primary completion
- 30 Jun 2028 (estimated)
- Study completion
- 29 Sep 2030 (estimated)
- First posted
- 25 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Maridebart Cafraglutide | Experimental | Drug: Maridebart CafraglutideParticipants will receive maridebart cafraglutide subcutaneously (SC). |
| Placebo | Placebo comparator | Drug: PlaceboParticipants will receive placebo SC. |
Who may qualify
- Ages
- 45 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age ≥ 45 years at screening.
- BMI of ≥ 27.0 kg/m^2 at screening.
- History of Atherosclerotic Cardiovascular Disease (ASCVD) with a documented history of at least one of the following:
Key exclusion criteria (15 listed)
- History of any of the following within 60 days before screening or between screening and randomization: MI, hospitalization for unstable angina, arterial revascularization (eg, coronary, cerebrovascular or peripheral) major cardiovascular surgery, stroke, or transient ischemic attack (TIA).
- New York Heart Association (NYHA) class IV HF during screening or hospitalization for HF within 60 days before screening or between screening and randomization.
- Type 1 DM, or any other type of diabetes with the exception of T2DM or prior gestational diabetes. Participants with a history of gestational diabetes should be stratified according to their current diabetes classification.
- For participants with T2DM (including those without a prior history of T2DM but with a HbA1c ≥ 6.5% during screening):
- Use of any glucagon-like peptide-1 receptor agonist (GLP-1 RA), glucose-dependent insulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within 90 days before randomization or planned use during the conduct of the trial.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Maridebart CafraglutideAlso: AMG 133, MariTideMaridebart cafraglutide will be administered SC. | Drug | Maridebart Cafraglutide |
| PlaceboPlacebo will be administered SC. | Drug | Placebo |
Primary outcome
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, Myocardial Infarction (MI), or Ischemic Stroke (3-point Major Adverse Cardiac Events [3-P MACE])
Time frame: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of: All-cause Death, MI, Ischemic Stroke, Coronary Revascularization, or Heart Failure (HF) Event (5-point MACE)
Time frame: Up to approximately 35 months
48 secondary outcomes
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, MI, Ischemic Stroke, or HF Event
Time frame: Up to approximately 35 months
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, MI, Ischemic Stroke or Coronary Revascularization
Time frame: Up to approximately 35 months
Time to First MI
Time frame: Up to approximately 35 months
Time to First Ischemic Stroke
Time frame: Up to approximately 35 months
Time to CV Death
Time frame: Up to approximately 35 months
Time to All-cause Death
Time frame: Up to approximately 35 months
Time to First Coronary Revascularization
Time frame: Up to approximately 35 months
Time to First HF Event
Time frame: Up to approximately 35 months
Time to First HF Event or CV Death
Time frame: Up to approximately 35 months
Time to First Unstable Angina Requiring Hospitalization
Time frame: Up to approximately 35 months
Time to First Occurrence of MI or CV Death
Time frame: Up to approximately 35 months
Time to First Occurrence of MI, Ischemic Stroke or All-cause Death
Time frame: Up to approximately 35 months
Total Major Ischemic Events (Time to First and Recurrent MI or Ischemic Stroke)
Time frame: Up to approximately 35 months
Total All-cause Hospitalizations (Time to First and Recurrent Event)
Time frame: Up to approximately 35 months
Time to Onset of Type 2 Diabetes Mellitus (T2DM) in Participants with Prediabetes at Baseline
Time frame: Up to approximately 35 months
Time to Onset of T2DM in Participants without T2DM at Baseline
Time frame: Up to approximately 35 months
Change from Baseline in Systolic Blood Pressure (SBP) at Week 72
Time frame: Baseline and Week 72
Change from Baseline in Diastolic Blood Pressure (DBP) at Week 72
Time frame: Baseline and Week 72
Change from Baseline in Body Mass Index (BMI) at Week 72
Time frame: Baseline and Week 72
Change from Baseline in Waist Circumference at Week 72
Time frame: Baseline and Week 72
Change from Baseline in Urine Albumin-to-creatinine Ratio (uACR) at Week 72
Time frame: Baseline and Week 72
Change from Baseline in Hemoglobin A1c (HbA1c) at Week 72
Time frame: Baseline and Week 72
Change from Baseline in Fasting Plasma Glucose at Week 72
Time frame: Baseline and Week 72
Percent Change from Baseline in High-sensitivity C-reactive protein (hs-CRP) at Week 72
Time frame: Baseline and Week 72
Percent Change from Baseline in Body Weight at Week 72
Time frame: Baseline and Week 72
Percent Change from Baseline in Total Cholesterol at Week 72
Time frame: Baseline and Week 72
Percent Change from Baseline in High-density Lipoprotein Cholesterol (HDL-C) at Week 72
Time frame: Baseline and Week 72
Percent Change from Baseline in Low-density Lipoprotein Cholesterol (LDL-C) at Week 72
Time frame: Baseline and Week 72
Percent Change from Baseline in Triglycerides (TG) at Week 72
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.5% (48 mmol/mol) in Participants with T2DM at Baseline
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.0% (42 mmol/mol) in Participants with T2DM at Baseline
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 5.7% (39 mmol/mol) in Participants with T2DM at Baseline
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.5% (48 mmol/mol) in Participants Without T2DM at Baseline
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 6.0% (42 mmol/mol) in Participants Without T2DM at Baseline
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 5.7% (39 mmol/mol) in Participants Without T2DM at Baseline
Time frame: Baseline and Week 72
Number of Participants at Week 72 with HbA1c < 5.7% (39 mmol/mol) in Participants with HbA1c ≥ 5.7% and < 6.5% at Baseline
Time frame: Baseline and Week 72
Change from Baseline in Short Form 36 Health Survey Acute Version 2 (SF-36 v2) Physical Function Domain Score at Week 48
Time frame: Baseline and Week 48
Time to First Event of a Composite Nephropathy Endpoint
Time frame: Up to approximately 35 months
Change in eGFR (total slope) for the period from baseline to the final follow up visit
Time frame: Baseline up to approximately 35 months
Change in eGFR (chronic slope) for the period from 4 months to the final follow-up visit
Time frame: From 4 months up to approximately 35 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2026.
- AmgenTrials clinical trials websiteLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.
Related trials for Atherosclerotic Cardiovascular Disease
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Not yet recruiting
Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)
Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD)
Not yet recruiting
EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease
Atherosclerotic Cardiovascular Disease
Recruiting
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
Dyslipidemias, Atherosclerotic Cardiovascular Disease
Active, not recruitingObservational study
A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events (OPTIMUS RISK - Spain)
Atherosclerotic Cardiovascular Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
MD study director
Amgen
783 sites in 36 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Maridebart Cafraglutide in people with Atherosclerotic Cardiovascular Disease and Overweight, run by Amgen at 783 sites in 36 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 783 sites in United States, Czechia, China, Germany, Poland and 31 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to First Occurrence of a Composite Endpoint Consisting of: CV Death, Myocardial Infarction (MI), or Ischemic Stroke (3-point Major Adverse Cardiac Events [3-P MACE]) (time frame: Up to approximately 35 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026; AzTrials last refreshed its copy on 7 Nov 2026.